$35M Gift Creates Karsh Division of Interventional Cardiology

Cedars-Sinai today announced a $35 million gift from Martha and Bruce Karsh and the Karsh Family Foundation. The major donation includes $30 million to establish the Karsh Division of Interventional Cardiology and $5 million to create the Karsh Distinguished Chair in Interventional Cardiology. Both gifts are under the umbrella of the Smidt Heart Institute at Cedars-Sinai.

The Karsh family's contribution will advance care and research across the field of interventional cardiology at the medical center. Interventional cardiologyis a branch of medicine focusing specifically on minimally invasive, catheter-based procedures to correct structural heart problems such as leaking valves. The gift is in honor of Martha's mother, Sybil Lubin, a now-healthy and active 94-year-old who experienced a catastrophic mitral valve rupture two years ago. She credits Raj Makkar, MD, and the interventional cardiology team at Cedars-Sinai with saving her life.

Makkar is the inaugural director of the Karsh Division of Interventional Cardiology and will also serve as the Karsh Distinguished Chair in Interventional Cardiology. An authority in advanced catheter-based therapies, Makkar's team of experts treat more than 10,000 patients annually. Makkar says his mission is to perform and teach other physicians how to perform these advanced therapies so that many more patients can and will benefit.

"Our interventional cardiology programs are available around the clock to provide urgent care to those who need it most," said Makkar. "Thanks to the incredible generosity of the Karsh family, we not only are able to sustain this critical service but also enhance and grow it. Their gift makes them true partners in our mission, helping us continue to provide the highest level of care, and we are deeply grateful for their support."

Cardiovascular disease remains the leading cause of death globally, as cited by the World Health Organization. Cedars-Sinai ranked #1 in California and #6 nationally for Cardiology, Heart & Vascular Surgery in U.S. News & World Report's "Best Hospitals 2024-25" listings. The newly established interventional cardiology division will treat conditions including valvular defects, electrical rhythm disorders, heart muscle dysfunctions and congenital heart disease.

The Karsh family says mindful merging of a common mission is the basis for their partnership with Cedars-Sinai. "'Education, Community, Democracy' is a motto of our foundation," the family said. "With this gift, we aim to amplify our commitment to both our community and medical education. Ultimately, what we hope to contribute to the world of medicine on a global scale with Cedars-Sinai is a powerful testament to what results from intention put into action."

Peter L. Slavin, MD, president and CEO of Cedars-Sinai, expressed his gratitude for the Karsh family's generosity and commitment to the highest quality care.

"The Karsh family has an enduring commitment to transformative medicine, and they're building an even more profound legacy of philanthropy with the Karsh Division of Interventional Cardiology," said Slavin. This new gift adds to their past visionary contribution that birthed the nationally ranked Karsh Division of Gastroenterology and Hepatology. Both enterprises address vital areas primed for innovative, groundbreaking advancements with the resources required for our patients."

Read more on the Cedars-Sinai Newsroom: Smidt Heart Institute Advances Valve Replacement